Capricor Therapeutics, Inc. (CAPR)
NASDAQ
Market Cap
$648.4M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
40 of 963
Rank in Industry
32 of 552
Largest Insider Buys in Sector
CAPR Stock Price History Chart
CAPR Stock Performance
About Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Phase II clinical trial for the treatment of cytokine storm associated with SARS-CoV-2. The company also develops CAP-2003 that is in pre-clinical development for the treatment of trauma related injuries and conditions; and two vaccine candidates, which are in development stage for the potential prevention of COVID-19. It collaborates with Lonza Houston, Inc. for the clinical manufacturing of CAP-1002, its cell therapy candidate for the treatment of DMD and other indications. The company was founded in 2005 and is headquartered in San Diego, California.
Insider Activity of Capricor Therapeutics, Inc.
Over the last 12 months, insiders at Capricor Therapeutics, Inc. have bought $15M and sold $0 worth of Capricor Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Capricor Therapeutics, Inc. have bought $5.02M and sold $474.71M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Nippon Shinyaku Co Ltd (10 percent owner) — $15M.
The last purchase of 2,798,507 shares for transaction amount of $15M was made by Nippon Shinyaku Co Ltd (10 percent owner) on 2024‑09‑20.
List of Insider Buy and Sell Transactions, Capricor Therapeutics, Inc.
| 2024-09-20 | 10 percent owner | 2.8M 9.1284% | $5.36 | $15M | +268.32% | |||
| 2023-10-12 | director | 410 0.0015% | $2.75 | $1,128 | +63.96% | |||
| 2023-10-10 | director | 10,000 0.0395% | $2.83 | $28,300 | +62.63% | |||
| 2023-10-09 | director | 5,083 0.02% | $2.82 | $14,334 | +66.55% | |||
| 2023-10-06 | director | 5,000 0.019% | $2.84 | $14,200 | +58.10% | |||
| 2023-10-04 | director | 2,500 0.0095% | $2.90 | $7,250 | +61.27% | |||
| 2023-04-17 | Sale | 14,772 – | $64,258.00 | $949.22M | +3.50% | |||
| 2023-03-28 | Sale | 3,000 0.0118% | $4.06 | $12,180 | +6.59% | |||
| 2022-06-29 | Sale | 28,215 0.1163% | $3.77 | $106,371 | +19.68% | |||
| 2022-06-29 | CHIEF BUSINESS OFFICER | 1,500 0.0062% | $3.76 | $5,643 | +19.68% | |||
| 2022-06-27 | Sale | 17,775 0.0736% | $4.44 | $78,921 | +1.59% | |||
| 2017-05-09 | 10 percent owner | 2.29M 11.0606% | $3.10 | $7.1M | -46.21% | |||
| 2017-05-09 | director | 20,000 0.0966% | $3.10 | $62,000 | -46.21% | |||
| 2017-05-09 | director | 50,000 0.2415% | $3.10 | $155,000 | -46.21% | |||
| 2016-09-21 | 10 percent owner | 625,000 3.0673% | $3.20 | $2M | -26.89% | |||
| 2016-03-16 | 10 percent owner | 833,332 4.8375% | $2.40 | $2M | +29.40% | |||
| 2016-03-16 | director | 182,738 1.0608% | $2.40 | $438,571 | +29.40% | |||
| 2016-03-16 | 10 percent owner | 833,332 4.8375% | $2.40 | $2M | +29.40% | |||
| 2016-03-16 | Chief Executive Officer | 30,456 0.1768% | $2.40 | $73,094 | +29.40% | |||
| 2016-03-16 | director | 200,000 1.161% | $2.40 | $480,000 | +29.40% |
Insider Historical Profitability
15.38%
| Nippon Shinyaku Co Ltd | 10 percent owner | 7090351 15.5935% | $14.26 | 1 | 0 | |
| CEDARS SINAI MEDICAL CENTER | 10 percent owner | 4049959 8.9069% | $14.26 | 4 | 0 | +25.52% |
| Marban Eduardo | 10 percent owner | 3173354 6.979% | $14.26 | 2 | 0 | <0.0001% |
| KASH PETER M | director | 1596208 3.5105% | $14.26 | 3 | 0 | |
| TANEN DAVID M | director | 1520705 3.3444% | $14.26 | 4 | 0 | |
| GRASMICK LOUIS J | director | 1059740 2.3306% | $14.26 | 4 | 0 | +8.61% |
| St. John Edward A. | 10 percent owner | 842439 1.8527% | $14.26 | 2 | 0 | +25.52% |
| Marban Linda | Chief Executive Officer | 273709 0.602% | $14.26 | 3 | 0 | +1.25% |
| Manzo Louis | director | 138384 0.3043% | $14.26 | 3 | 0 | +25.52% |
| BREWER RICHARD B | Executive Chairman | 125000 0.2749% | $14.26 | 1 | 0 | |
| Kazam Joshua A | director | 38084 0.0838% | $14.26 | 9 | 0 | +21.63% |
| Musket David B | director | 31536 0.0694% | $14.26 | 5 | 2 | +21.63% |
| COLLIER EARL M JR | director | 26856 0.0591% | $14.26 | 1 | 0 | |
| Evans Daron | Chief Financial Officer | 25652 0.0564% | $14.26 | 7 | 0 | |
| Lieu Hsiao | Executive VP, Clinical Dev. | 12600 0.0277% | $14.26 | 2 | 0 | |
| Krasney Karen | EVP, General Counsel | 11156 0.0245% | $14.26 | 2 | 0 | +25.52% |
| Strumph Peter M | Chief Executive Officer | 7580 0.0167% | $14.26 | 3 | 0 | |
| Auwaerter Paul Gisbert | director | 5000 0.011% | $14.26 | 1 | 0 | |
| GERSHELL LELAND | CHIEF FINANCIAL OFFICER | 2100 0.0046% | $14.26 | 1 | 0 | +29.4% |
| Bergmann Anthony | Vice President of Finance | 2030 0.0045% | $14.26 | 1 | 0 | +29.4% |
| SCHAFER GREGORY W | director | 100 0.0002% | $14.26 | 1 | 0 | |
| Avat Xavier | 0 0% | $14.26 | 1 | 1 | +19.68% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| The Vanguard Group | $9.27M | 4.29 | 1.37M | +17.2% | +$1.36M | <0.0001 | |
| BlackRock | $2.59M | 1.2 | 381,735 | +6.13% | +$149,801.00 | <0.0001 | |
| Geode Capital Management | $2.23M | 1.03 | 328,477 | +3.88% | +$83,391.31 | <0.0001 | |
| Susquehanna International Group | $2.15M | 0.99 | 316,260 | +112.09% | +$1.13M | <0.01 | |
| Millennium Management LLC | $1.99M | 0.92 | 293,041 | +1,292.91% | +$1.85M | <0.01 | |
| Goldman Sachs | $1.45M | 0.67 | 213,169 | +1,298.75% | +$1.34M | <0.0001 | |
| Advisor Group Holdings Inc | $1.07M | 0.5 | 158,200 | +35.74% | +$282,803.50 | <0.01 | |
| Northern Trust | $816,933.00 | 0.38 | 120,314 | -5.43% | -$46,952.90 | <0.0001 | |
| State Street | $792,556.00 | 0.37 | 116,724 | +36.96% | +$213,885.01 | <0.0001 | |
| Morgan Stanley | $757,743.00 | 0.35 | 111,597 | +134.01% | +$433,941.75 | <0.0001 | |
| Arrowstreet Capital, Limited Partnership | $689,000.00 | 0.32 | 101,542 | New | +$689,000.00 | <0.01 | |
| Jane Street Capital | $629,161.00 | 0.29 | 92,660 | +131.42% | +$357,296.36 | <0.01 | |
| JPMorgan Chase | $618,454.00 | 0.29 | 91,083 | New | +$618,454.00 | <0.0001 | |
| Hrt Financial Llc | $560,000.00 | 0.26 | 82,557 | New | +$560,000.00 | <0.01 | |
| Wellington Management Company | $541,564.00 | 0.25 | 79,759 | New | +$541,564.00 | <0.0001 | |
| Citigroup | $532,010.00 | 0.25 | 78,352 | +229.24% | +$370,421.60 | <0.0001 | |
| Man Group Plc | $494,971.00 | 0.23 | 72,897 | New | +$494,971.00 | <0.01 | |
| BNY Mellon | $480,339.00 | 0.22 | 70,742 | -16.54% | -$95,175.59 | <0.0001 | |
| Qube Research & Technologies | $471,246.00 | 0.22 | 69,403 | +26.17% | +$97,735.18 | <0.01 | |
| Jump Financial Llc | $379,650.00 | 0.18 | 55,913 | +5.9% | +$21,137.31 | <0.01 | |
| Cubist Systematic Strategies | $368,480.00 | 0.17 | 54,268 | New | +$368,480.00 | <0.01 | |
| Renaissance Technologies | $361,000.00 | 0.17 | 53,150 | -63.68% | -$632,826.55 | <0.01 | |
| Walleye Capital | $323,516.00 | 0.15 | 47,646 | New | +$323,516.00 | <0.01 | |
| LINSCO PRIVATE LEDGER CORP | $314,635.00 | 0.15 | 46,338 | -40.77% | -$216,600.99 | <0.0001 | |
| Wells Fargo | $221,096.00 | 0.1 | 32,562 | +13,697.46% | +$219,493.56 | <0.0001 | |
| Citadel Advisors LLC | $209,152.00 | 0.1 | 30,803 | New | +$209,152.00 | <0.0001 | |
| Occudo Quantitative Strategies Lp | $176,927.00 | 0.08 | 26,057 | New | +$176,927.00 | 0.03 | |
| Simplex Trading Llc | $171,000.00 | 0.08 | 25,197 | -41.05% | -$119,055.96 | 0.01 | |
| ExodusPoint Capital Management, LP | $167,000.00 | 0.08 | 24,570 | New | +$167,000.00 | <0.01 | |
| Two Sigma | $162,960.00 | 0.08 | 24,000 | +21.83% | +$29,197.00 | <0.0001 | |
| Point72 Asia Singapore Pte Ltd | $160,774.00 | 0.07 | 23,678 | New | +$160,774.00 | 0.02 | |
| Bank of America | $149,394.00 | 0.07 | 22,002 | -7.27% | -$11,719.57 | <0.0001 | |
| Main Street Financial Solutions Llc | $135,800.00 | 0.06 | 20,000 | New | +$135,800.00 | 0.02 | |
| Y Intercept Hong Kong Ltd | $132,656.00 | 0.06 | 19,537 | +90.36% | +$62,970.35 | 0.01 | |
| Brevan Howard Capital Management Lp | $132,188.00 | 0.06 | 19,468 | New | +$132,188.00 | 0.01 | |
| OMERS | $122,220.00 | 0.06 | 18,000 | New | +$122,220.00 | <0.01 | |
| Charles Schwab | $91,522.00 | 0.04 | 13,479 | 0% | +$0 | <0.0001 | |
| Balyasny Asset Management Llc | $88,229.00 | 0.04 | 12,994 | New | +$88,229.00 | <0.0001 | |
| Woodline Partners LP | $84,610.00 | 0.04 | 12,461 | -98.63% | -$6.09M | <0.01 | |
| Coastal Bridge Advisors Llc | $73,970.00 | 0.03 | 10,894 | 0% | +$0 | 0.02 | |
| Jefferies Financial Group | $71,974.00 | 0.03 | 10,600 | New | +$71,974.00 | <0.01 | |
| Prudential Financial | $67,900.00 | 0.03 | 10,000 | New | +$67,900.00 | <0.0001 | |
| U.S. Bancorp | $50,667.00 | 0.02 | 7,462 | 0% | +$0 | <0.0001 | |
| Tower Research Capital | $32,816.00 | 0.02 | 4,833 | +255.37% | +$23,581.62 | <0.0001 | |
| LAZARD ASSET MANAGEMENT LLC | $17,000.00 | 0.01 | 2,693 | New | +$17,000.00 | <0.0001 | |
| UBS | $10,185.00 | 0.01 | 1,500 | New | +$10,185.00 | <0.0001 | |
| Householder Group Estate Retirement Specialist Llc | $10,185.00 | 0.01 | 1,500 | 0% | +$0 | <0.01 | |
| Royal Bank of Canada | $10,000.00 | <0.01 | 1,400 | -85.97% | -$61,271.43 | <0.0001 | |
| Hightower Advisors | $6,000.00 | <0.01 | 901 | New | +$6,000.00 | <0.0001 | |
| Macquarie Group | $6,000.00 | <0.01 | 941 | New | +$6,000.00 | <0.0001 |
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.